chr18-79467476-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000587635.5(NFATC1):​c.1901A>G​(p.His634Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.326 in 1,602,740 control chromosomes in the GnomAD database, including 89,656 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 13320 hom., cov: 32)
Exomes 𝑓: 0.32 ( 76336 hom. )

Consequence

NFATC1
ENST00000587635.5 missense

Scores

8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.08

Publications

14 publications found
Variant links:
Genes affected
NFATC1 (HGNC:7775): (nuclear factor of activated T cells 1) The product of this gene is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation, and an inducible nuclear component. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. The product of this gene is an inducible nuclear component. It functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Different isoforms of this protein may regulate inducible expression of different cytokine genes. [provided by RefSeq, Jul 2013]
NFATC1 Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.4692257E-5).
BP6
Variant 18-79467476-A-G is Benign according to our data. Variant chr18-79467476-A-G is described in ClinVar as Benign. ClinVar VariationId is 1668933.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000587635.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFATC1
NM_001278669.2
MANE Select
c.1986A>Gp.Pro662Pro
synonymous
Exon 8 of 10NP_001265598.1
NFATC1
NM_172387.3
c.1947A>Gp.Pro649Pro
synonymous
Exon 8 of 10NP_765975.1
NFATC1
NM_006162.5
c.1986A>Gp.Pro662Pro
synonymous
Exon 8 of 10NP_006153.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFATC1
ENST00000587635.5
TSL:1
c.1901A>Gp.His634Arg
missense
Exon 8 of 8ENSP00000468111.1
NFATC1
ENST00000427363.7
TSL:1 MANE Select
c.1986A>Gp.Pro662Pro
synonymous
Exon 8 of 10ENSP00000389377.2
NFATC1
ENST00000329101.8
TSL:1
c.1947A>Gp.Pro649Pro
synonymous
Exon 8 of 10ENSP00000327850.3

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
60228
AN:
151900
Hom.:
13294
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.608
Gnomad AMI
AF:
0.352
Gnomad AMR
AF:
0.344
Gnomad ASJ
AF:
0.327
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.322
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.367
GnomAD2 exomes
AF:
0.325
AC:
80474
AN:
247962
AF XY:
0.315
show subpopulations
Gnomad AFR exome
AF:
0.604
Gnomad AMR exome
AF:
0.326
Gnomad ASJ exome
AF:
0.318
Gnomad EAS exome
AF:
0.382
Gnomad FIN exome
AF:
0.308
Gnomad NFE exome
AF:
0.309
Gnomad OTH exome
AF:
0.306
GnomAD4 exome
AF:
0.319
AC:
462826
AN:
1450722
Hom.:
76336
Cov.:
36
AF XY:
0.315
AC XY:
227056
AN XY:
720626
show subpopulations
African (AFR)
AF:
0.619
AC:
19617
AN:
31680
American (AMR)
AF:
0.324
AC:
14302
AN:
44136
Ashkenazi Jewish (ASJ)
AF:
0.316
AC:
8139
AN:
25724
East Asian (EAS)
AF:
0.386
AC:
15162
AN:
39306
South Asian (SAS)
AF:
0.220
AC:
18822
AN:
85376
European-Finnish (FIN)
AF:
0.316
AC:
16804
AN:
53252
Middle Eastern (MID)
AF:
0.299
AC:
1709
AN:
5712
European-Non Finnish (NFE)
AF:
0.315
AC:
348509
AN:
1105628
Other (OTH)
AF:
0.330
AC:
19762
AN:
59908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
15110
30219
45329
60438
75548
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11596
23192
34788
46384
57980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.397
AC:
60309
AN:
152018
Hom.:
13320
Cov.:
32
AF XY:
0.392
AC XY:
29141
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.608
AC:
25188
AN:
41440
American (AMR)
AF:
0.345
AC:
5262
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
1136
AN:
3472
East Asian (EAS)
AF:
0.372
AC:
1915
AN:
5150
South Asian (SAS)
AF:
0.223
AC:
1075
AN:
4824
European-Finnish (FIN)
AF:
0.322
AC:
3406
AN:
10586
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.311
AC:
21157
AN:
67960
Other (OTH)
AF:
0.362
AC:
766
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1758
3517
5275
7034
8792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
542
1084
1626
2168
2710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
23247
Bravo
AF:
0.412
TwinsUK
AF:
0.308
AC:
1142
ALSPAC
AF:
0.317
AC:
1220
ESP6500AA
AF:
0.606
AC:
2671
ESP6500EA
AF:
0.323
AC:
2780
ExAC
AF:
0.331
AC:
40147
Asia WGS
AF:
0.301
AC:
1046
AN:
3476
EpiCase
AF:
0.307
EpiControl
AF:
0.311

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NFATC1-related disorder Benign:1
Oct 22, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.022
DANN
Benign
0.25
DEOGEN2
Benign
0.014
T
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.18
T
MetaRNN
Benign
0.000055
T
PhyloP100
-4.1
Vest4
0.038
GERP RS
-9.4
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs25656; hg19: chr18-77227476; COSMIC: COSV53698423; COSMIC: COSV53698423; API